Skip to main content
. 2008 Feb;19(2):225–232. doi: 10.1681/ASN.2007010029

Figure 1.

Figure 1.

Changes in urine flow rate (A) and urine osmolality (B) in Brattleboro rats of controls (CTR) and with SR treatment (SR) (protocol 1). V2 receptor antagonist SR was given twice a day for 3 d by subcutaneous injection. After SR administration urine flow rate was increased dramatically at day 1 and was still higher at days 2 and 3 but did not reach statistical significance. SR treatment decreased urine osmolality significantly compared with CTR rats. *P < 0.05, SR rats versus CTR rats.